Stay updated on Proviral Genotype-Guided ART Clinical Trial
Sign up to get notified when there's something new on the Proviral Genotype-Guided ART Clinical Trial page.

Latest updates to the Proviral Genotype-Guided ART Clinical Trial page
- CheckyesterdayChange DetectedThe study page now shows a 403 Forbidden error, replacing the detailed study record content with an access-restricted error page. This blocks users from viewing the trial's basic information and related details.SummaryDifference17%

- Check8 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a software/version upgrade for the Study Details page. This appears to reflect maintenance or enhancements rather than changes to the study data or content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe revision tag on the page has been updated from v3.6.5 to v3.6.6, indicating a minor system update. This change does not alter the study content, eligibility criteria, or publicly visible information.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded a new line, 2017 ( U.S. NIH Grant/Contract ), under Other Study ID Numbers, indicating NIH funding for the ART-PRO study. This reveals the NIH support associated with the trial.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, signaling a new version of the page. This appears to be a minor update with no specific user-facing changes described.SummaryDifference0.1%

- Check57 days agoChange DetectedThe revision label on the page was updated from v3.6.3 to v3.6.4, indicating a minor platform update reflected in the site’s revision banner.SummaryDifference0.1%

Stay in the know with updates to Proviral Genotype-Guided ART Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Proviral Genotype-Guided ART Clinical Trial page.